Painreform Stock In The News

PRFX Stock  USD 3.20  0.96  23.08%   
Our overall analysis of Painreform's news coverage and content from conventional and social sources shows investors' bearish mood towards Painreform. The specific impact of Painreform news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Painreform's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Painreform headlines in addition to utilizing other, more conventional financial analysis modules. Check out Painreform Backtesting and Painreform Hype Analysis.
For more information on how to buy Painreform Stock please use our How to Invest in Painreform guide.

Painreform Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
PainReform Provides Business Update for the Third Quarter of 2023
https://www.globenewswire.com/news-release/2023/11/15/2781411/0/en/PainReform-Provides-Business-Update-for-the-Third-Quarter-of-2023.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Announces Plans to Commence S...
https://www.globenewswire.com/news-release/2023/09/11/2740807/0/en/PainReform-Announces-Plans-to-Commence-Second-Part-of-Phase-3-Clinical-Trial-to-Evaluate-PRF-110-in-Patients-Undergoing-Bunionectomy-Surgery-Following-Positive-FDA-Review-of-Drug-M.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary
https://www.globenewswire.com/news-release/2023/09/07/2739531/0/en/PainReform-Selected-for-Poster-Presentation-at-the-13th-Congress-of-the-European-Pain-Federation-in-Budapest-Hungary.html
 Bullish
Macroaxis News: globenewswire.com
PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City
https://www.globenewswire.com/news-release/2023/09/05/2737361/0/en/PainReform-to-Participate-in-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference-in-New-York-City.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Provides Business Update for the Second Quarter of 2023
https://www.globenewswire.com/news-release/2023/08/10/2723145/0/en/PainReform-Provides-Business-Update-for-the-Second-Quarter-of-2023.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Regains Compliance with Nasdaq Continued Listing Requirements
https://www.globenewswire.com/news-release/2023/07/19/2707351/0/en/PainReform-Regains-Compliance-with-Nasdaq-Continued-Listing-Requirements.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement
https://www.globenewswire.com/news-release/2023/07/14/2705091/0/en/PainReform-Announces-Pricing-of-1-5-Million-Concurrent-Registered-Direct-Offering-and-Private-Placement.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
https://www.globenewswire.com/news-release/2023/07/12/2703592/0/en/PainReform-Announces-Pricing-of-2-7-Million-Concurrent-Registered-Direct-Offering-and-Private-Placement.html
 Bullish
Macroaxis News: globenewswire.com
PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21st
https://www.globenewswire.com/news-release/2023/06/15/2688886/0/en/PainReform-to-Present-at-the-Maxim-Group-Virtual-Healthcare-Conference-Hosted-by-M-Vest-on-June-21st.html
 Bullish
Macroaxis News: globenewswire.com
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
https://www.globenewswire.com/news-release/2023/06/07/2684256/0/en/PainReform-Provides-Regulatory-Update-on-Second-Part-of-its-Phase-3-Clinical-Trial-of-PRF-110-in-Patients-Undergoing-Bunionectomy-Surgery.html
 Bullish

Painreform Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Painreform and other traded companies coverage with news coverage. We help investors stay connected with Painreform headlines for the 22nd of November to make an informed investment decision based on correlating the impacts of news items on Painreform Stock performance. Please note that trading solely based on the Painreform hype is not for everyone as timely availability and quick action are needed to avoid losses.
Painreform's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Painreform investors visualize upcoming and past events in order to time the market based on Painreform noise-free hype analysis.
Painreform stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Painreform earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Painreform that are available to investors today. That information is available publicly through Painreform media outlets and privately through word of mouth or via Painreform internal channels. However, regardless of the origin, that massive amount of Painreform data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Painreform news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Painreform relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Painreform's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Painreform alpha.

Painreform Largest EPS Surprises

Earnings surprises can significantly impact Painreform's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-15
2022-09-30-0.17-0.1983-0.028316 
2023-05-16
2023-03-31-0.32-0.220.131 
2023-03-15
2022-12-31-0.15-0.3-0.15100 
2021-11-16
2021-09-30-0.43-0.180.2558 
2024-05-15
2024-03-31-2.4-2.72-0.3213 
2021-05-13
2021-03-31-0.56-0.230.3358 
View All Earnings Estimates

Painreform Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Painreform Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
benzinga news
20th of November 2024
US Stocks Mostly Lower Target Posts Downbeat Earnings
at benzinga.com 
benzinga news
19th of November 2024
PainReform Stock Is Soaring Tuesday Whats Going On
at benzinga.com 
Google News at Macroaxis
18th of September 2024
PRFX stock touches 52-week low at 0.74 amid sharp annual decline - Investing.com
at news.google.com 
seekingalpha News
10th of September 2024
PainReform to raise 1.58M through exercise of warrants
at seekingalpha.com 
Google News at Macroaxis
4th of September 2024
PainReform Announces Reverse Share Split - TipRanks
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Painreform in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Painreform's short interest history, or implied volatility extrapolated from Painreform options trading.

Additional Tools for Painreform Stock Analysis

When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.